Sai Parenteral's Limited (BOM:544742)

Market Cap	21.28B
Revenue (ttm)	1.63B +6.1%
Net Income	144.54M
EPS	5.43
Shares Out	n/a
PE Ratio	147.25
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,442
Average Volume	79,965
Open	490.70
Previous Close	489.35
Day's Range	468.00 - 495.15
52-Week Range	392.00 - 523.40
Beta	n/a
RSI	n/a
Earnings Date	n/a

About Sai Parenteral's

Sai Parenteral's Limited, a pharmaceutical formulations company, engages in the branded generic formulations and contract development and manufacturing businesses in India and internationally. Its portfolio includes formulation products across various therapeutic areas, such as cardiovascular, neuropsychiatry, anti-diabetic, respiratory health, antibiotics, gastroenterology, vitamins, minerals and supplements, analgesics, and dermatology in various dosage forms, including injectables, tablets, capsules, liquid orals, and ointments. The company ...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1988
• Employees: 296
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 544742

Financial Performance

In fiscal year 2025, Sai Parenteral's's revenue was 1.63 billion, an increase of 6.08% compared to the previous year's 1.54 billion. Earnings were 144.54 million, an increase of 71.76%.